EPKIN
LIVE

Serial Number

98814954

Owner

EPKIN

Attorney

Andrew D. Bochner

Filing Date

Oct 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EPKIN Trademark

Serial Number: 98814954

EPKIN is a trademark filed by EPKIN on October 22, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

EPKIN (2 trademarks)

14-16 boulevard Poissonnière
Paris F-75009 , FR

Entity Type: 99

Trademark Details

Filing Date

October 22, 2024

Registration Date

Not Registered

Published for Opposition

April 28, 2026

Goods & Services

Medical services; Medical diagnostic services; Pharmaceutical advice; Providing medical information to medical professionals in the form of reports in the field of oncology; Medical services in the field of oncology

Downloadable artificial intelligence and machine learning software for developing, running and analyzing algorithms that are able to learn to analyze, classify, and take actions in response to exposure to data; Downloadable artificial intelligence software for healthcare for developing, running and analyzing algorithms that are able to learn to analyze, classify, and take actions in response to exposure to data; Downloadable computer software and programs using artificial intelligence for data and software processing, generation, understanding and analysis; downloadable computer programs and downloadable computer software for artificial intelligence, namely, computer software for developing, running and analyzing algorithms that are able to learn to analyze, classify, and take actions in response to exposure to data; downloadable computer software for simulation environments for the purpose of testing artificial intelligence agents, algorithms or programs; Downloadable computer software and programs for diagnosing health condition, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analysing medical images, analysing data, and developing pharmaceuticals and chemical compounds

Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for activities relating to experimentation, design, research and development of therapeutic strategies and pharmaceutical specialties, biology and biochemistry; Research in the field of artificial intelligence technology; Technology consultation in the field of artificial intelligence; Software as a service (SaaS) featuring software for diagnosing health condition, prescribing treatments and writing prescriptions, designing clinical tests and forecasting clinical test results, searching for clinical trial participants, analysing medical images, analysing data, and developing pharmaceuticals and chemical compounds; Scientific and technological services, namely, experimentation being testing, design, research and development of therapeutic strategies and pharmaceutical specialties, biology and biochemistry in the field of oncology; Advisory services relating to scientific research; Scientific research; Engineering services; Technical consultancy services relating to computer programming; Research and development services in the field of engineering; Development of computer programs for others; Software design and development; Consultancy relating to research and development in the field of therapeutics solutions and pharmaceutical products; Scientific research in the nature of conducting clinical trials for others for pharmaceutical products; Scientific research in the nature of conducting clinical trials in the field of oncology; Scientific research relating to biology; Research and development in the field of biochemistry

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 9, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 29, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 18, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 11, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2025 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2025 NWOS
NEW APPLICATION ENTERED
Oct 22, 2024 NWAP